Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-02ACHV3Form 3 Filing for Reid Waldman
This filing reports that Reid Waldman, a director at ACHIEVE LIFE SCIENCES, INC. (ACHV), has no securities beneficially owned following a transaction as of May 29, 2026. The filing includes a Limited Power of Attorney, appointing Sandra Thomson to execute and file necessary SEC forms (3, 4, 5) on behalf of Mr. Waldman....
Small CapBiotechnology
2026-06-01SPRY3Power of Attorney for Donn Casale
This filing documents a Power of Attorney granted by Donn Casale, President of ARS Pharmaceuticals, Inc., to Richard Lowenthal, Kathleen Scott, and Justin Chakma. The attorneys-in-fact are authorized to execute and file Forms 3, 4, and 5 on behalf of Mr. Casale with the SEC and other authorities, as required by Section...
Small CapBiotechnology
2026-06-01ANL3Form 3 Filing by Ye Xiaofeng, CFO of Adlai Nortye Ltd.MEDIUM
This Form 3 filing reports initial beneficial ownership of securities by Ye Xiaofeng, the Chief Financial Officer (CFO) of Adlai Nortye Ltd. The filing indicates direct ownership of 159,424 American Depositary Shares (ADS). Additionally, it reports indirect ownership of 31 ADS held by family members. The filing also de...
Small CapBiotechnology
2026-06-01ARS Pharmaceuticals, Inc.3Power of Attorney for Donn CasaleDuplicate
This filing documents a Power of Attorney granted by Donn Casale, President of ARS Pharmaceuticals, Inc., to Richard Lowenthal, Kathleen Scott, and Justin Chakma. The attorneys-in-fact are authorized to execute and file Forms 3, 4, and 5 on behalf of Mr. Casale with the SEC and other authorities, as required by Section...
Small CapBiotechnology